Tag Archive for: surgical outcomes

Posts

Article of the Week: Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery

Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post.

In addition to the article itself, there is an accompanying editorial written by a prominent member of the urological community. This blog is intended to provoke comment and discussion and we invite you to use the comment tools at the bottom of each post to join the conversation.

Finally, the third post under the Article of the Week heading on the homepage will consist of additional material or media. This week we feature a video from Craig Rogers, discussing his paper.

If you only have time to read one article this week, it should be this one.

Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery

 

Newaj Abdullah*, Haider Rahbar*, Ravi Barod*, Deepansh Dalela*, Jeff LarsonMichael Johnson, Alon Mass§, Homayoun Zargar, Mohamad Allaf, Sam BhayaniMichael Stifelman§, Jihad Kaouk¶ and Craig Rogers*

 

*Vattikutti Urology Institute, Henry Ford Health System, Detroit, MI, Division of Urology, Washington University in St. Louis, St. Louis, MO, James Buchanan Brady Urological Institute, John Hopkins University, Baltimore, MD, §Department of Urology, New York University, New York, NY, and Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

 

Objective

To evaluate the outcomes of robot-assisted partial nephrectomy RAPN after major prior abdominal surgery (PAS) using a large multicentre database.

Patients and methods

We identified 1 686 RAPN from five academic centres between 2006 and 2014. In all, 216 patients had previously undergone major PAS, defined as having an open upper midline/ipsilateral incision. Perioperative outcomes were compared with those 1 470 patients who had had no major PAS. The chi-squared test and Mann–Whitney U-test were used for categorical and continuous variables, respectively.

AugAOTW4FI

Results

There was no statistically significant difference in Charlson comorbidity index, tumour size, R.E.N.A.L. nephrometry score or preoperative estimated glomerular filtration rate (eGFR) between the groups. Age and body mass index were higher in patients with PAS. The PAS group had a higher estimated blood loss (EBL) but this did not lead to a higher transfusion rate. A retroperitoneal approach was used more often in patients with major PAS (11.2 vs 5.4%), although this group did not have a higher percentage of posterior tumours (38.8 vs 43.3%, P = 0.286). Operative time, warm ischaemia time, length of stay, positive surgical margin, percentage change in eGFR, and perioperative complications were not significantly different between the groups.

Conclusions

RAPN in patients with major PAS is safe and feasible, with increased EBL but no increased rate of transfusion. Patients with major PAS had almost twice the likelihood of having a retroperitoneal approach.

Editorial: Robot-assisted partial nephrectomy: excellent outcomes can persist despite previous abdominal surgery

Robot-assisted surgery is increasing and patient selection is important to ensure mitigation of risk, patient safety and allow for the surgeon’s training curve. This is especially pertinent for robot-assisted partial nephrectomy (RAPN), as increasingly complex tumours and increasingly complex patients are considered potentially suitable. One factor that contributes to patient complexity is the presence of intra-abdominal adhesions, which can be predicted by previous abdominal surgery. This month’s article by Abdullah et al. [1] ‘Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery’ eloquently describes their outcomes in patients who underwent RAPN with a history of previous open abdominal surgery.

The study retrospectively analysed 1 686 patients who had undergone RAPN from a prospective database from five large American academic institutions. A sub-group of 216 patients (13%) had undergone major prior abdominal surgery (PAS); this was defined as those marked by upper midline or ipsilateral incisions. The authors chose such incisions due to the increased potential for adhesions within the expected surgical field for RAPN, which could interfere with performance [2]. The list of prior surgeries is wide ranging such as laparotomy, open cholecystectomy, open appendicectomy and open ipsilateral PN; 12% (25 patients) had had multiple previous procedures.

The study found that there was no statistical difference between the two groups in the areas of Charlson comorbidities index, tumour size, R.E.N.A.L. nephrometry score [consists of (R)adius (tumour size as maximal diameter), (E)xophytic/endophytic properties of the tumour, (N)earness of tumour deepest portion to the collecting system or sinus, (A)nterior (a)/posterior (p) descriptor and the (L)ocation relative to the polar line], and preoperative estimated GFR. They also found no difference between intraoperative and postoperative complications (<4% Clavien ≥3 in PAS group), positive surgical margins and change in renal function.

Their initial concern that previous surgery increases robotic operative time was ill founded, as there was no statistical difference in median (interquartile range) operative times: PAS 172 (132–224) vs169 (139–208) min. However, they did find statistical difference in estimated blood loss, which was higher in the PAS group (150 vs 100 mL; P = 0.039); but this did not translate to a difference in transfusion rates.

They also found the PAS patients were older (median 63 vs 60 years) and had a higher median body mass index (30.3 vs 29 kg/m2). This is an important finding in the context of offering robotic minimally invasive surgery in an increasingly obese and ageing surgical population.

Achieving safe access is a crucial step in all laparoscopic or robot-assisted surgery and is potentially complicated by the presence of adhesions. It was of particular interest to read of the access techniques used: Hasson vs Veress needle vs retroperitoneal approach. The latter was used more in the PAS group (11.2% vs 5.4%), despite a lower percentage of posterior tumours (38.8% vs 43.3%). This suggests surgical preference for choosing a retroperitoneal approach was related to avoidance of potential adhesions rather than tumour location.

Conceptually the Hassan technique, with access achieved by direct vision, could offer safety benefits in the presence of potential adhesions; however, access via Veress needle insufflation occurred in most of their cases. The authors describe the use of the Hassan technique in instances of failure of Veress access but the incidence that this occurred is not provided. They estimated that 24 cases were converted to open due to access-related issues.

Further interrogation of the 180 open PNs performed during the study period could provide a valuable comparative group and understand why they were not deemed suitable for a robot-assisted approach.

The study can be commended for its large patient database, multicentre design, and breadth of outcomes assessed. It supports the findings of Zargar et al. [3] showing comparable perioperative complications and open conversions of RAPN in patients with and without a history of PAS in their similar sized, but single-centre study. This is also in agreement with assessments of other robotic procedures supporting the relative safety of robotic surgery in patients with a history of PAS.

One of the limitations of this study is the lack of discussion on the decision-making process for choice of access technique. Individual surgeons and/or the recommendations of multi-disciplinary teams will favour the technique with the perceived best outcome and may select out more favourable cases to each arm. Abdullah et al. [1] results may be an indication of appropriate technique selection rather than safety of the robot or individual access techniques.

This study provides robotic surgeons with increasing confidence to offer RAPN and its potential advantages of reduced blood loss, pain and recovery time to patients despite the presence of potential adhesions from PAS. Individual case selection remains imperative to maintain optimal surgical outcomes. Complex cases may be safely tackled in high-volume established RAPN programmes; but they may not be suitable for surgeons earlier in their experience. Robotic surgeons should be well trained and confident in managing the potential complications of bowel injury in these challenging cases.

Sophie Rintoul-Hoad, Rick Catterwell and Ben Challacombe
Urology Centre, Guys and St Thomas Hospitals NHS Trust, Great Maze Pond, London, UK

 

Read the full article

 

References

 

1 Abdullah N, Rahbar H, Barod R et al. Multicentre outcomes of robot- assisted partial nephrectomy after major open abdominal surgery. BJU Int 2016; 118: 298301

 

2 Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical signicance. Recent advances in prevention and management. Dig Surg 2001; 18: 26073

 

 

Video: Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery

Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery

Newaj Abdullah*, Haider Rahbar*, Ravi Barod*, Deepansh Dalela*, Jeff LarsonMichael Johnson, Alon Mass§, Homayoun Zargar, Mohamad Allaf, Sam BhayaniMichael Stifelman§, Jihad Kaouk¶ and Craig Rogers*

 

*Vattikutti Urology Institute, Henry Ford Health System, Detroit, MI, Division of Urology, Washington University in St. Louis, St. Louis, MO, James Buchanan Brady Urological Institute, John Hopkins University, Baltimore, MD, §Department of Urology, New York University, New York, NY, and Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

 

Objective

To evaluate the outcomes of robot-assisted partial nephrectomy RAPN after major prior abdominal surgery (PAS) using a large multicentre database.

Patients and methods

We identified 1 686 RAPN from five academic centres between 2006 and 2014. In all, 216 patients had previously undergone major PAS, defined as having an open upper midline/ipsilateral incision. Perioperative outcomes were compared with those 1 470 patients who had had no major PAS. The chi-squared test and Mann–Whitney U-test were used for categorical and continuous variables, respectively.

AugAOTW4FI

Results

There was no statistically significant difference in Charlson comorbidity index, tumour size, R.E.N.A.L. nephrometry score or preoperative estimated glomerular filtration rate (eGFR) between the groups. Age and body mass index were higher in patients with PAS. The PAS group had a higher estimated blood loss (EBL) but this did not lead to a higher transfusion rate. A retroperitoneal approach was used more often in patients with major PAS (11.2 vs 5.4%), although this group did not have a higher percentage of posterior tumours (38.8 vs 43.3%, P = 0.286). Operative time, warm ischaemia time, length of stay, positive surgical margin, percentage change in eGFR, and perioperative complications were not significantly different between the groups.

Conclusions

RAPN in patients with major PAS is safe and feasible, with increased EBL but no increased rate of transfusion. Patients with major PAS had almost twice the likelihood of having a retroperitoneal approach.

Article of the week: Outcomes of PCNL in England

Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post.

In addition to the article itself, there is an accompanying editorial written by a prominent member of the urological community. This blog is intended to provoke comment and discussion and we invite you to use the comment tools at the bottom of each post to join the conversation.

Finally, the third post under the Article of the Week heading on the homepage will consist of additional material or media. This week we feature a video from Mr. Armitage and Mr. Withington discussing their article.

If you only have time to read one article this week, it should be this one

Percutaneous nephrolithotomy in England: practice and outcomes described in the Hospital Episode Statistics database

James N. Armitage, John Withington*, Jan van der Meulen*, David A. Cromwell*, Jonathan Glass, William G. Finch§, Stuart O. Irving§ and Neil A. Burgess§

Department of Urology, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, *Clinical Effectiveness Unit, The Royal College of Surgeons of England, Department of Urology, Guy’s & St Thomas’ NHS Foundation Trust, London School of Hygiene and Tropical Medicine, London, and §Department of Urology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK

Read the full article
OBJECTIVE

• To investigate the postoperative outcomes of percutaneous nephrolithotomy (PCNL) in English National Health Service (NHS) hospitals.

PATIENTS AND METHODS

• We extracted records from the Hospital Episode Statistics (HES) database for all patients undergoing PCNL between March 2006 and January 2011 in English NHS hospitals.

• Outcome measures were haemorrhage, infection within the index admission, and rates of emergency readmission and in-hospital mortality within 30 days of surgery.

RESULTS

• A total of 5750 index PCNL procedures were performed in 165 hospitals.

• During the index admission, haemorrhage was recorded in 81 patients (1.4%), 192 patients (3.8%) had a urinary tract infection (UTI), 95 patients (1.7%) had fever, and 41 patients (0.7%) had sepsis.

• There were 595 emergency readmissions in 518 patients (9.0%). Reasons for readmission were varied: 70 (1.2%) with UTI, 15 (0.3%) sepsis, 73 (1.3%) haematuria, 25 (0.4%) haemorrhage, and 25 (0.4%) acute urinary retention.

• There were 13 (0.2%) in-hospital deaths within 30 days of surgery.

CONCLUSIONS

• Haemorrhage and infection represent relatively common and potentially severe complications of PCNL.

• Mortality is extremely rare after PCNL (about one in 400 procedures overall) but almost one in 10 patients have an unplanned hospital readmission within 30 days of surgery.

• Complications of PCNL may be under-reported in the HES database and need to be corroborated using other data sources.

 

Editorial: How are we doing with percutaneous nephrolithotomy in England?

Over the past several years, with publications of studies evaluating multiple aspects of nephrolithiasis using large databases, our overview of kidney stone disease has vastly expanded. The most recent addition by Armitage et al. [1], published in this issue of BJUI, gives us a view of percutaneous nephrolithotomy (PCNL) outcomes in England that we otherwise would have difficulty seeing without tapping into a database study. Several salient features of this investigation are worth pointing out.

With any study comes the uncertainty of its validity. Evidence-based medicine (EBM) theory dictates we first ask ‘Are the results valid?’ rather than ‘What are the results?’. This study reports similar outcomes to a prior database study of the BAUS, giving us confidence that data from different sources still produce somewhat similar outcomes, hence adding validity to both studies [2]. Moreover, it is further reassuring that the type of epidemiological source of the information was derived from completely different origins, i.e. Armitage et al. [1] used an administrative database from Hospital Episode Statistics (HES) to create their outcomes while the BAUS used a voluntary online prospective database for British surgeons.

The second question that forms the basis of EBM is ‘What are the results?’. The HES data confirmed several findings of PCNL seen in other studies, including in both international series from the Clinical Research Office of the Endourological Society (CROES) as well as American administrative database studies using the Nationwide Inpatient Sample (NIS) [3-5]. Overall complications occur anywhere from 6% to 15% of the time, with the most common complications including infection and bleeding. Compared with these recent studies, the HES study reports lower bleeding, UTI and sepsis rates, which the authors admit could represents an under-reporting phenomenon. Mortality is an exceedingly rare event in all these studies. Overall, complication rates are comparable and give us assurance that they align approximately with other worldwide data. Another important finding with the HES database is the decreased length of stay for patients over time. Lastly, from a physician credentialing standpoint this study has relevant findings. It suggests that the HES administrative database may be a viable source of information to assist in the surgeon validating process.

Weaknesses of administrative database studies include the lack of detail that prospective clinical databases provide. Clinically pertinent PCNL endpoints are inherently absent for both patient and surgical domains. Missing patient information includes stone size, stone-free rates, and patient obesity, which are all reflections of clinical case difficulty. Missing critical surgical information includes where (upper, mid or lower calyx), who (urologist or radiologist) and how (balloon, serial dilators) access is obtained. As mentioned above, the uncertainty of under-coding clinical information always exists.

Why are large database studies, including this article, important? These studies are timely given the recent advocating of retrograde ureteroscopic treatment of large renal calculi [6]. Publication of low complication rates with equal efficacy in an outpatient setting has made ureteroscopic treatment of partial and staghorn renal calculi attractive. Even laparoscopic anatrophic nephrolithotomy has been advocated to further challenge the ‘gold standard’ treatment of PCNL [7]. It is therefore clinically important that British PCNL complication rates are low and that length of stay is decreasing to affirm the role that PCNL has with large renal calculi.

The role of PCNL surgery for renal calculi continues to develop but, more importantly, the value of these large epidemiological studies also continues to grow. They help us to look not only from the ground level but also give us perspective from a different, if not ‘higher’ level, which taken together helps shapes our interpretation of PCNL.

Roger L. Sur

Department of Urology, UC San Diego Health System, San Diego, CA, USA

Read the full article

References

  1. Armitage JN, Withington J, Van der Meulen J et al. Percutaneous nephrolithotomy in England: practice and outcomes described in the hospital episode statistics database. BJU Int 2014; 113: 777–782
  2. Armitage JN, Irving SO, Burgess NA, British Association of Urological Surgeons Section of Endourology. Percutaneous nephrolithotomy in the United Kingdom: results of a prospective data registry. Eur Urol 2012; 61: 1188–1193
  3. de la Rosette J, Assimos D, Desai M et al. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients. J Endourol 2011; 25: 11–17
  4. Mirheydar HS, Palazzi KL, Derweesh IH, Chang DC, Sur RL. Percutaneous nephrolithotomy use is increasing in the United States: an analysis of trends and complications. J Endourol 2013; 27: 979–983
  5. Ghani KR, Sammon JD, Bhojani N et al. Trends in percutaneous nephrolithotomy use and outcomes in the United States. J Urol 2013; 190: 558–564
  6. Aboumarzouk OM, Monga M, Kata SG, Traxer O, Somani BK. Flexible ureteroscopy and laser lithotripsy for stones >2 cm: a systematic review and meta-analysis. J Endourol 2012; 26: 1257–1263
  7. Aminsharifi A, Hadian P, Boveiri K. Laparoscopic anatrophic nephrolithotomy for management of complete staghorn renal stone: clinical efficacy and intermediate-term functional outcome. J Endourol 2013; 27: 573–578

 

Video: PCNL practice and outcomes in England

Percutaneous nephrolithotomy in England: practice and outcomes described in the Hospital Episode Statistics database

James N. Armitage, John Withington*, Jan van der Meulen*, David A. Cromwell*, Jonathan Glass, William G. Finch§, Stuart O. Irving§ and Neil A. Burgess§

Department of Urology, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, *Clinical Effectiveness Unit, The Royal College of Surgeons of England, Department of Urology, Guy’s & St Thomas’ NHS Foundation Trust, London School of Hygiene and Tropical Medicine, London, and §Department of Urology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK

Read the full article
OBJECTIVE

• To investigate the postoperative outcomes of percutaneous nephrolithotomy (PCNL) in English National Health Service (NHS) hospitals.

PATIENTS AND METHODS

• We extracted records from the Hospital Episode Statistics (HES) database for all patients undergoing PCNL between March 2006 and January 2011 in English NHS hospitals.

• Outcome measures were haemorrhage, infection within the index admission, and rates of emergency readmission and in-hospital mortality within 30 days of surgery.

RESULTS

• A total of 5750 index PCNL procedures were performed in 165 hospitals.

• During the index admission, haemorrhage was recorded in 81 patients (1.4%), 192 patients (3.8%) had a urinary tract infection (UTI), 95 patients (1.7%) had fever, and 41 patients (0.7%) had sepsis.

• There were 595 emergency readmissions in 518 patients (9.0%). Reasons for readmission were varied: 70 (1.2%) with UTI, 15 (0.3%) sepsis, 73 (1.3%) haematuria, 25 (0.4%) haemorrhage, and 25 (0.4%) acute urinary retention.

• There were 13 (0.2%) in-hospital deaths within 30 days of surgery.

CONCLUSIONS

• Haemorrhage and infection represent relatively common and potentially severe complications of PCNL.

• Mortality is extremely rare after PCNL (about one in 400 procedures overall) but almost one in 10 patients have an unplanned hospital readmission within 30 days of surgery.

• Complications of PCNL may be under-reported in the HES database and need to be corroborated using other data sources.

 

© 2024 BJU International. All Rights Reserved.